Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Evaluation of Adrabetadex in Patients With Neurologic Manifestations of Niemann-Pick Type C Disease (NPC)

NCT03643562 is registered in ClinicalTrials.gov with Mandos LLC as lead sponsor.

NCT NCT03643562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03643562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Evaluation of Adrabetadex in Patients With Neurologic Manifestations of Niemann-Pick Type C Disease (NPC)
Lead sponsor
Mandos LLC
Phase
Phase 3
Overall status
Terminated
Start date
June 18, 2018
Completion date
November 2, 2021
Enrollment
27 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

niemann-pick type c disease